Publikationen in Zusammenarbeit mit Forschern von University of Tartu (8)

2022

  1. Human genetic and immunological determinants of critical COVID-19 pneumonia

    Nature, Vol. 603, Núm. 7902, pp. 587-598

2020

  1. A dynamic COVID-19 immune signature includes associations with poor prognosis

    Nature Medicine, Vol. 26, Núm. 10, pp. 1623-1635

  2. Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis (Nature Medicine, (2020), 26, 10, (1623-1635), 10.1038/s41591-020-1038-6)

    Nature Medicine

  3. Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis (Nature Medicine, (2020), 26, 10, (1623-1635), 10.1038/s41591-020-1038-6)

    Nature Medicine

  4. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  5. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2018

  1. Extracellular vesicle heterogeneity: Subpopulations, isolation techniques, and diverse functions in cancer progression

    Frontiers in Immunology, Vol. 9, Núm. APR

2007

  1. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension

    European Journal of Ophthalmology, Vol. 17, Núm. 2, pp. 183-190